The study has highlighted some key challenges facing the pharmaceuticals to optimally enhance the capacity building initiative via microemulsion encapsulation technology.Research on the microencapsulation technology for local improvement has grown rapidly in the recent years. The specific goal of this technology is to design, develop and test a portfolio of tools for the joint identification & exploitation of pharmacological research in targeted domains of pharmaceutical interest. The work reported covers various investigations carried out under microemulsion conditions. More specifically it includes the encapsulation of nonsteroid anti-inflammatory drug (piroxicam) and the preparation and recovery of cetyltrimethylammonium chloride (CTACl) capped metal nanoparticles (Au, Pd, SiO2). Microemulsions are colloidal self-assembly fluids, function as nanoreactors and are suitable replacement for enhancing the loading capacity of drugs and recovery of nanoparticles. It was found that high loading capacity of piroxicam (1 wt%) and paramount recovery of nanoparticles (upto 98%) highlight the proficiency of the microemulsions in pharmaceuticals and in separation science